Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Stroke Research and Treatment, enter your email address in the box below.

Stroke Research and Treatment
Volume 2014 (2014), Article ID 234095, 9 pages
http://dx.doi.org/10.1155/2014/234095
Clinical Study

Autologous Bone Marrow Mononuclear Cells Intrathecal Transplantation in Chronic Stroke

Alok Sharma,1 Hemangi Sane,2 Nandini Gokulchandran,1 Dipti Khopkar,2 Amruta Paranjape,2 Jyothi Sundaram,3 Sushant Gandhi,3 and Prerna Badhe1

1Department of Medical Services and Clinical Research, NeuroGen Brain and Spine Institute, Stemasia Hospital and Research Centre, Plot No. 19, Sector 40, Near Seawoods Railway Station, Nerul, Navi Mumbai, Maharashtra 400706, India
2Department of Research and Development, NeuroGen Brain and Spine Institute, Stemasia Hospital and Research Centre, Plot No. 19, Sector 40, Near Seawoods Railway Station, Nerul, Navi Mumbai, Maharashtra 400706, India
3Department of Neurorehabilitation, NeuroGen Brain and Spine Institute, Stemasia Hospital and Research Centre, Plot No. 19, Sector 40, Near Seawoods Railway Station, Nerul, Navi Mumbai, Maharashtra 400706, India

Received 9 April 2014; Revised 17 June 2014; Accepted 22 June 2014; Published 8 July 2014

Academic Editor: Wuwei Feng

Copyright © 2014 Alok Sharma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Langhorne, J. Bernhardt, and G. Kwakkel, “Stroke rehabilitation,” The Lancet, vol. 377, no. 9778, pp. 1693–1702, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Dharmasaroja, “Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke,” Journal of Clinical Neuroscience, vol. 16, no. 1, pp. 12–20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Brainin, Y. Teuschl, and L. Kalra, “Acute treatment and long-term management of stroke in developing countries,” The Lancet Neurology, vol. 6, no. 6, pp. 553–561, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. C. V. Borlongan, “Bone marrow stem cell mobilization in stroke: a bonehead may be good after all!,” Leukemia, vol. 25, no. 11, pp. 1674–1686, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. R. Carter, L. T. Connor, and A. W. Dromerick, “Rehabilitation after stroke: current state of the science,” Current Neurology and Neuroscience Reports, vol. 10, no. 3, pp. 158–166, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Brewer, F. Horgan, A. Hickey, and D. Williams, “Stroke rehabilitation: recent advances and future therapies,” QJM, vol. 106, no. 1, pp. 11–25, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. J. D. Flax, S. Aurora, C. Yang et al., “Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes,” Nature Biotechnology, vol. 16, no. 11, pp. 1033–1438, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. F. H. Gage, P. W. Coates, T. D. Palmer et al., “Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 25, pp. 11879–11883, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Liu, B. T. Himes, J. Solowska et al., “Intraspinal delivery of neurotrophin-3 using neural stem cells genetically modified by recombinant retrovirus,” Experimental Neurology, vol. 158, no. 1, pp. 9–26, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Muñoz-Elias, D. Woodbury, and I. B. Black, “Marrow stromal cells, mitosis, and neuronal differentiation: stem cell and precursor functions,” Stem Cells, vol. 21, no. 4, pp. 437–448, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. D. C. Hess and C. V. Borlongan, “Cell-based therapy in ischemic stroke,” Expert Review of Neurotherapeutics, vol. 8, no. 8, pp. 1193–1201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Hara, T. Yasuhara, M. Maki et al., “Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke,” Progress in Neurobiology, vol. 85, no. 3, pp. 318–334, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. D. C. Hess and C. V. Borlongan, “Stem cells and neurological diseases,” Cell Proliferation, vol. 41, no. 1, pp. 94–114, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Zhao, W. Duan, M. Reyes, C. D. Keene, C. M. Verfaillie, and W. C. Low, “Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats,” Experimental Neurology, vol. 174, no. 1, pp. 11–20, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. W. C. Shyu, S. Z. Lin, M. F. Chiang, C. Su, and H. Li, “Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing β1 integrin-mediated angiogenesis in chronic stroke rats,” The Journal of Neuroscience, vol. 26, no. 13, pp. 3444–3453, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Pavlichenko, I. Sokolova, S. Vijde et al., “Mesenchymal stem cells transplantation could be beneficial for treatment of experimental ischemic stroke in rats,” Brain Research, vol. 1233, pp. 203–213, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Chen, Z. G. Zhang, Y. Li et al., “Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats,” Circulation Research, vol. 92, no. 6, pp. 692–699, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Li, J. Chen, L. Wang, M. Lu, and M. Chopp, “Treatment of stroke in rat with intracarotid administration of marrow stromal cells,” Neurology, vol. 56, no. 12, pp. 1666–1672, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Jeong, K. Chu, K. Jung, S. U. Kim, M. Kim, and J. Roh, “Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage,” Stroke, vol. 34, no. 9, pp. 2258–2263, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. D. C. Hess, W. D. Hill, A. Martin-Studdard, J. Carroll, J. Brailer, and J. Carothers, “Bone marrow as a source of endothelial cells and NeuN-expressing cells after stroke,” Stroke, vol. 33, no. 5, pp. 1362–1368, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. O. Y. Bang, J. S. Lee, P. H. Lee, and G. Lee, “Autologous mesenchymal stem cell transplantation in stroke patients,” Annals of Neurology, vol. 57, no. 6, pp. 874–882, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. J. S. Lee, J. M. Hong, G. J. Moon, P. H. Lee, Y. H. Ahn, and O. Y. Bang, “A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke,” Stem Cells, vol. 28, no. 6, pp. 1099–1106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. R. V. Carlson, K. M. Boyd, and D. J. Webb, “The revision of the Declaration of Helsinki: past, present and future,” The British Journal of Clinical Pharmacology, vol. 57, no. 6, pp. 695–713, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Chen and M. Chopp, “Neurorestorative treatment of stroke: cell and pharmacological approaches,” NeuroRx, vol. 3, no. 4, pp. 466–473, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. J. M. Parent, Z. S. Vexler, C. Gong, N. Derugin, and D. M. Ferriero, “Rat forebrain neurogenesis and striatal neuron replacement after focal stroke,” Annals of Neurology, vol. 52, no. 6, pp. 802–813, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Arvidsson, T. Collin, D. Kirik, Z. Kokaia, and O. Lindvall, “Neuronal replacement from endogenous precursors in the adult brain after stroke,” Nature Medicine, vol. 8, no. 9, pp. 963–970, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. R. J. Nudo, “Functional and structural plasticity in motor cortex: implications for stroke recovery,” Physical Medicine and Rehabilitation Clinics of North America, vol. 14, no. 1, pp. S57–S76, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. R. J. Nudo, E. J. Plautz, and S. B. Frost, “Role of adaptive plasticity in recovery of function after damage to motor cortex,” Muscle and Nerve, vol. 24, no. 8, pp. 1000–1019, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. R. P. Stroemer, T. A. Kent, and C. E. Hulsebosch, “Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats,” Stroke, vol. 29, no. 11, pp. 2381–2395, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Dezawa, M. Hoshino, Y. Nabeshima, and C. Ide, “Marrow stromal cells: Implications in health and disease in the nervous system,” Current Molecular Medicine, vol. 5, no. 7, pp. 723–732, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Chen, Y. Li, L. Wang et al., “Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats,” Stroke, vol. 32, no. 4, pp. 1005–1011, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Li, J. Chen, C. L. Zhang et al., “Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells,” Glia, vol. 49, no. 3, pp. 407–417, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. L. H. Shen, Y. Li, J. Chen et al., “Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke,” Journal of Cerebral Blood Flow and Metabolism, vol. 27, pp. 6–11, 2006. View at Google Scholar
  34. S. Wislet-Gendebien, F. Bruyère, G. Hans, P. Leprince, G. Moonen, and B. Rogister, “Nestin-positive mesenchymal stem cells favour the astroglial lineage in neural progenitors and stem cells by releasing active BMP4,” BMC Neuroscience, vol. 5, article 33, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Carmeliet and E. Storkebaum, “Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders,” Seminars in Cell and Developmental Biology, vol. 13, no. 1, pp. 39–53, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Jin, Y. Zhu, Y. Sun, X. O. Mao, L. Xie, and D. A. Greenberg, “Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 18, pp. 11946–11950, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Sharma and N. Gokulchandran, “Mechanism of action,” in Stem cell Therapy in Neurological Disorders, A. Sharma and N. Gokulchnadran, Eds., pp. 61–69, Surekha Press, Mumbai, India, 2010. View at Google Scholar
  38. A. Mahmood, D. Lu, M. Lu et al., “Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells,” Neurosurgery, vol. 53, no. 3, pp. 697–703, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Sharma, H. Sane, A. Paranjape et al., “Positron emission tomography—computer tomography scan used as a monitoring tool following cellular therapy in cerebral palsy and mental retardation—a case report,” Case Reports in Neurological Medicine, vol. 2013, Article ID 141983, 6 pages, 2013. View at Publisher · View at Google Scholar
  40. A. Sharma, P. Kulkarni, H. Sane et al., “Positron emission tomography—computed tomography scan captures the effects of cellular therapy in a case of cerebral palsy,” Journal of Clinical Case Reports, vol. 2, no. 13, 2012. View at Google Scholar
  41. A. Sharma, N. Gokulchandran, G. Chopra et al., “Administration of autologous bone marrow-derived mononuclear cells in children with incurable neurological disorders and injury is safe and improves their quality of life,” Cell Transplantation, vol. 21, no. 1, pp. S79–S90, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Sharma, N. Gokulchandran, H. Sane et al., “Detailed analysis of the clinical effects of cell therapy for thoracolumbar spinal cord injury: an original study,” Journal of Neurorestoratology, vol. 1, pp. 13–22, 2013. View at Google Scholar
  43. A. Sharma, H. Sane, N. Gokulchandran et al., “Role of autologous bone marrow mononuclear cells in chronic cervical spinal cord injury—a longterm follow up study,” Journal of Neurological Disorders, vol. 1, no. 4, 2013. View at Google Scholar
  44. A. Sharma, P. Badhe, P. Kulkarni et al., “Autologous bone marrow derived mononuclear cells for the treatment of spinal cord injury,” The Journal of Orthopaedic and Trauma Surgery, vol. 1, no. 1, pp. 33–36, 2011. View at Google Scholar
  45. A. Sharma, N. Gokulchandran, G. Chopra et al., “Administration of autologous bone marrow-derived mononuclear cells in children with incurable neurological disorders and injury is safe and improves their quality of life,” Cell Transplantation, vol. 21, supplement 1, pp. S79–S90, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Sharma, H. Sane, P. Badhe et al., “Autologous bone marrow stem cell therapy shows functional improvement in hemorrhagic stroke,” Indian Journal of Clinical Practice, vol. 23, no. 2, pp. 100–105, 2012. View at Google Scholar
  47. A. Stolzing, E. Jones, D. McGonagle, and A. Scutt, “Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies,” Mechanisms of Ageing and Development, vol. 129, no. 3, pp. 163–173, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. H. W. Mahncke, A. Bronstone, and M. M. Merzenich, “Chapter 6 Brain plasticity and functional losses in the aged: scientific bases for a novel intervention,” Progress in Brain Research, vol. 157, pp. 81–109, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. G. S. Smith, “Aging and neuroplasticity,” Guest Editorial.
  50. P. Arora, S. Yardi, and N. Siddiqui, “Effect of core muscle strengtheneing on blance and quality of life in geriatric patients,” Indian Journal of Physiotherapy & Occupational Therapy, vol. 7, no. 2, p. 120, 2013. View at Google Scholar
  51. H. Nakayama, H. S. Jørgensen, H. O. Raaschou, and T. S. Olsen, “The influence of age on stroke outcome: the Copenhagen Stroke Study,” Stroke, vol. 25, no. 4, pp. 808–813, 1994. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Salter, J. Jutai, M. Hartley et al., “Impact of early vs delayed admission to rehabilitation on functional outcomes in persons with stroke,” Journal of Rehabilitation Medicine, vol. 38, no. 2, pp. 113–117, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. C. S. Piao, M. E. Gonzalez-Toledo, Y. Q. Xue et al., “The role of stem cell factor and granulocyte-colony stimulating factor in brain repair during chronic stroke,” Journal of Cerebral Blood Flow and Metabolism, vol. 29, no. 4, pp. 759–770, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. P. J. Kelly, K. L. Furie, S. Shafqat, N. Rallis, Y. Chang, and J. Stein, “Functional recovery following rehabilitation after hemorrhagic and ischemic stroke,” Archives of Physical Medicine and Rehabilitation, vol. 84, no. 7, pp. 968–972, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. C. V. Granger, B. B. Hamilton, and R. C. Fiedler, “Discharge outcome after stroke rehabilitation,” Stroke, vol. 23, no. 7, pp. 978–982, 1992. View at Publisher · View at Google Scholar · View at Scopus
  56. A. U. Hicks, K. Hewlett, V. Windle et al., “Enriched environment enhances transplanted subventricular zone stem cell migration and functional recovery after stroke,” Neuroscience, vol. 146, no. 1, pp. 31–40, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. M. E. Raichle, “Visualizing the mind.,” Scientific American, vol. 270, no. 4, pp. 58–64, 1994. View at Google Scholar · View at Scopus
  58. E. K. J. Pauwels, M. J. Ribeiro, J. H. M. B. Stoot, V. R. McCready, M. Bourguignon, and B. Mazière, “FDG accumulation and tumor biology,” Nuclear Medicine and Biology, vol. 25, no. 4, pp. 317–322, 1998. View at Publisher · View at Google Scholar · View at Scopus
  59. J. A. Thie, “Understanding the standardized uptake value, its methods, and implications for usage,” Journal of Nuclear Medicine, vol. 45, no. 9, pp. 1431–1434, 2004. View at Google Scholar · View at Scopus